References
- Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
- Braveman PA, Heck K, Egerter S, et al. The role of socioeconomic factors in Black-White disparities in preterm birth. Am J Public Health. 2015;105(4):694–702.
- Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379–2385.
- Cohen AW, Copel JA, Macones GA, et al. Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α- hydroxyprogesterone caproate.). Obstet Gynecol. 2011;117(6):1408–1412.
- Smith VK, Gifford K, Ellis E, et al. Implementing coverage and payment initiatives: results from a 50-state medicaid budget survey for state fiscal years 2016 and 2017. San Francisco (CA): The Henry J. Kaiser Family Foundation; 2016.
- 2019 March of Dimes Report Card [Internet]. Arlington (VA): March of Dimes; 2019. [cited 2020 Feb 26]. Available from: www.marchofdimes.org/reportcard
- Maternal and Child Health Data [Internet]. Lansing (MI): Michigan Department of Health & Human Services; 2019. [cited 2020 Feb 26]. Available from: www.michigan.gov/mdch.
- R: A language and environment for statistical computing [Internet]. Vienna (Austria): R Foundation for Statistical Computing; 2017 [cited 2020 Feb 26]. Available from: http://www.R-project.org/.
- Blackwell SC, Gyamfi-Bannerman C, Biggio Jr JR, et al. 17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial. Am J Perinatol. 2020;37(02):127–136.
- McCabe ER, Carrino GE, Russell RB, et al. Fighting for the next generation: US prematurity in 2030. Pediatrics. 2014;134(6):1193–1197.
- Schoen CN, Tabbah S, Iams JD, et al. Why the United States preterm birth rate is declining. Am J Obstet Gynecol. 2015;213(2):175–180.